Publications and Patents

For more information or copies of Deciphera publications, contact us at 785.830.2100 or info@deciphera.com.

  • 04.2011

    "The ABL Switch Control Inhibitor DCC-2036 Is Active against the Chronic Myeloid Leukemia Mutant BCR-ABLT315I and Exhibits a Narrow Resistance Profile", Cancer Research, Volume 71, Issue 9, 3189-95, April 2011

  • 04.2011

    “Conformational Control Inhibition of the BCR-ABL1 Tyrosine Kinase, Including the Gatekeeper T315I Mutant, by the Switch-Control Inhibitor DCC-2036”, Cancer Cell, Volume 19, Issue 4, 556-568, April 2011

  • 01.2011

    "Targeted Inhibition of Multiple Receptor Tyrosine Kinases in Mesothelioma." Neoplasia, Volume 13, Number 1 , 12-22, January 2011

  • 10.2010

    "Switch Control Pocket Inhibitors of p38-MAP Kinase. Durable Type II Inhibitors that do not Require Binding into the Canonical ATP Hinge Region", Bioorg. Med. Chem Letters, Vol 20, Issue 19, 5793-5798, October 2010